Form 8-K - Current report:
SEC Accession No. 0001641172-25-017590
Filing Date
2025-07-02
Accepted
2025-07-02 17:01:52
Documents
12
Period of Report
2025-06-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 51987
  Complete submission text file 0001641172-25-017590.txt   220209

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocx-20250627.xsd EX-101.SCH 3077
3 XBRL LABEL FILE ocx-20250627_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE ocx-20250627_pre.xml EX-101.PRE 22401
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3691
Mailing Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217
Business Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217 949-409-7600
Insight Molecular Diagnostics Inc. (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 251102309
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)